Contact Us
Anti-Allergy Medicine Global Market Report 2025
Global Anti-Allergy Medicine Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Anti-Allergy Medicine Global Market Report 2025

By Drug Class (Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, Mast Cell Stabilizers, Other Drug Classes), By Type Of Allergy (Seasonal Allergies, Perennial Allergies, Food Allergies, Skin Allergies, Insect Sting Allergies), By Formulation (Tablets, Capsules, Syrups, Nasal Sprays, Eye Drops, Injectables), By Application (Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Other Applications), By End User (Children, Adults, Geriatric Population, Pregnant Women) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Anti-Allergy Medicine Market?

Anti-allergy medicine refers to a broad category of pharmaceutical products designed to prevent or alleviate the symptoms caused by allergic reactions by targeting the immune system’s response to allergens such as pollen, dust, pet dander, insect stings, or certain foods and medications. These medicines help reduce symptoms such as sneezing, itching, runny nose, hives, and watery eyes and reduce discomfort caused by allergens.

The main drug classes of anti-allergy medicine include antihistamines, corticosteroids, decongestants, leukotriene inhibitors, mast cell stabilizers, and others. Antihistamines are medications that help relieve allergy symptoms by blocking the effects of histamine, a chemical released by the immune system during allergic reactions. It is used to treat different types of allergies, including seasonal allergies, perennial allergies, food allergies, skin allergies, and insect sting allergies, and is divided by formulation into tablets, capsules, syrups, nasal sprays, eye drops, and injectables. Anti-allergy medicine is categorized by application into online pharmacy, hospital, offline pharmacy, clinic, and others, serving various end users such as children, adults, geriatric population, and pregnant women.

Anti-Allergy Medicine Market Size and growth rate 2025 to 2029: Graph

What Is The Anti-Allergy Medicine Market Size 2025 And Growth Rate?

The anti-allergy medicine market size has grown strongly in recent years. It will grow from $38.84 billion in 2024 to $42.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of allergic diseases, growing awareness about allergy treatments, rising adoption of over-the-counter anti-allergy medicines, expansion of healthcare infrastructure, and growing improvements in diagnostic technologies.

What Is The Anti-Allergy Medicine Market Growth Forecast?

The anti-allergy medicine market size is expected to see strong growth in the next few years. It will grow to $58.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing incidence of allergies worldwide, rising demand for fast-acting anti-allergy drugs, growing geriatric population, expansion of online pharmacy channels, and increasing government initiatives for allergy awareness. Major trends in the forecast period include technology advancements in drug delivery systems, innovations in non-sedating antihistamines, developments in personalized allergy treatments, research and development in biologics for allergy, and integration of digital health tools for allergy management.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Anti-Allergy Medicine Market Segmented?

The anti-allergy medicine market covered in this report is segmented –

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, Mast Cell Stabilizers, Other Drug Classes

2) By Type Of Allergy: Seasonal Allergies, Perennial Allergies, Food Allergies, Skin Allergies, Insect Sting Allergies

3) By Formulation: Tablets, Capsules, Syrups, Nasal Sprays, Eye Drops, Injectables

4) By Application: Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Other Applications

5) By End User: Children, Adults, Geriatric Population, Pregnant Women

Subsegments:

1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines, Third-Generation Antihistamines

2) By Corticosteroids: Oral Corticosteroids, Nasal Corticosteroids, Inhaled Corticosteroids, Topical Corticosteroids

3) By Decongestants: Oral Decongestants, Nasal Spray Decongestants, Topical Decongestants

4) By Leukotriene Inhibitors: Leukotriene Receptor Antagonists, Leukotriene Synthesis Inhibitors

5) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil Sodium

6) By Other Drug Classes: Immunotherapy Agents, Biologics, Monoclonal Antibodies

What Is Driving The Anti-Allergy Medicine Market? Growing Prevalence Of Allergies Fueling The Growth Of The Market Due To Rising Environmental Pollution And Increasing Asthma Cases

The growing prevalence of allergies is expected to propel the growth of the anti-allergy medicine market going forward. Allergies refer to hypersensitive immune responses to allergens such as pollen, dust mites, food, or pet dander, causing symptoms ranging from mild irritation to severe, life-threatening reactions. It includes hay fever, asthma, eczema, food allergies, and allergic rhinitis. The growing prevalence of allergies is due to increasing environmental pollution, as pollutants weaken the immune system and heighten sensitivity to common allergens. Anti-allergy medicines help manage allergies by providing targeted relief from allergens, making them essential for individuals with conditions such as hay fever, asthma, and eczema. They reduce immune overreactions by blocking histamines and other triggers, improving daily comfort and quality of life. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of people with asthma rose from 24,963,874 in 2021 to 26,799,588 in 2022. Therefore, the growing prevalence of allergies is driving the growth of the anti-allergy medicine market.

Who Are The Major Players In The Global Anti-Allergy Medicine Market?

Major companies operating in the anti-allergy medicine market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Perrigo Company plc, Cipla Limited, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd., ALK-Abelló A/S, Torii Pharmaceutical Co. Ltd., Biomay Aktiengesellschaft, Kaléo Inc., Immunomic Therapeutics Inc., Circassia Group plc, Sun Pharmaceutical Industries Ltd., Anergis S.A., Aravax Pty Ltd., DBV Technologies S.A., Desentum Oy.

What Are The Key Trends Of The Global Anti-Allergy Medicine Market? Targeted Allergy Therapy Gains Approval For Adolescent And Adult Use

Major companies operating in the anti-allergy medicine market are focusing on developing innovative therapies and getting approvals, such as monoclonal antibody therapies, to provide targeted treatment, improve efficacy, reduce side effects, and address chronic and severe allergic conditions. Monoclonal antibody therapies refer to laboratory-made proteins that mimic the immune system’s ability to fight harmful allergens by specifically targeting and blocking immune pathways involved in allergic reactions, offering precise and long-lasting relief. For instance, in December 2024, Galderma SA, a Switzerland-based pharmaceutical company, received approval from the Food and Drug Administration (FDA) for Nemluvio (nemolizumab-ilto) for the treatment of adults and pediatric patients 12 years of age and older with moderate to severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors. This monoclonal antibody is an interleukin-31 receptor antagonist that works by blocking IL-31 signaling, a key driver of inflammation and itch in atopic dermatitis, thereby reducing symptoms and improving skin condition.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Anti-Allergy Medicine Market? Johnson & Johnson Acquires Proteologix To Boost Immunology Pipeline

In January 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for $850 million. With this acquisition, Johnson & Johnson aims to strengthen its immunology portfolio by integrating Proteologix’s bispecific antibody programs to develop innovative treatments for immune-mediated diseases such as atopic dermatitis and asthma. Proteologix Inc. is a US-based biotechnology company focused on anti-allergy medicine through novel bispecific antibody therapies for conditions such as asthma and atopic dermatitis.

What Is The Regional Outlook For The Global Anti-Allergy Medicine Market?

North America was the largest region in the anti-allergy medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-allergy medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-allergy medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-Allergy Medicine Market?

The anti-allergy medicine market consists of sales of combination therapies, inhalers, nebulizers, auto-injectors, prefilled syringes, and transdermal patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anti-Allergy Medicine Industry?

The anti-allergy medicine market research report is one of a series of new reports from The Business Research Company that provides anti-allergy medicine market statistics, including the anti-allergy medicine industry global market size, regional shares, competitors with the anti-allergy medicine market share, detailed anti-allergy medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the anti-allergy medicine industry. These anti-allergy medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Anti Allergy Medicine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $42.25 billion
Revenue Forecast In 2034 $58.47 billion
Growth Rate CAGR of 8.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The anti-allergy medicine market covered in this report is segmented –
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, Mast Cell Stabilizers, Other Drug Classes
2) By Type Of Allergy: Seasonal Allergies, Perennial Allergies, Food Allergies, Skin Allergies, Insect Sting Allergies
3) By Formulation: Tablets, Capsules, Syrups, Nasal Sprays, Eye Drops, Injectables
4) By Application: Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Other Applications
5) By End User: Children, Adults, Geriatric Population, Pregnant Women Subsegments:
1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines, Third-Generation Antihistamines
2) By Corticosteroids: Oral Corticosteroids, Nasal Corticosteroids, Inhaled Corticosteroids, Topical Corticosteroids
3) By Decongestants: Oral Decongestants, Nasal Spray Decongestants, Topical Decongestants
4) By Leukotriene Inhibitors: Leukotriene Receptor Antagonists, Leukotriene Synthesis Inhibitors
5) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil Sodium
6) By Other Drug Classes: Immunotherapy Agents, Biologics, Monoclonal Antibodies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Perrigo Company plc, Cipla Limited, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd., ALK-Abelló A/S, Torii Pharmaceutical Co. Ltd., Biomay Aktiengesellschaft, Kaléo Inc., Immunomic Therapeutics Inc., Circassia Group plc, Sun Pharmaceutical Industries Ltd., Anergis S.A., Aravax Pty Ltd., DBV Technologies S.A., Desentum Oy.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Anti-Allergy Medicine Market Characteristics

3. Anti-Allergy Medicine Market Trends And Strategies

4. Anti-Allergy Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Anti-Allergy Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Anti-Allergy Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Anti-Allergy Medicine Market Growth Rate Analysis

5.4. Global Anti-Allergy Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Anti-Allergy Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Anti-Allergy Medicine Total Addressable Market (TAM)

6. Anti-Allergy Medicine Market Segmentation

6.1. Global Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antihistamines

Corticosteroids

Decongestants

Leukotriene Inhibitors

Mast Cell Stabilizers

Other Drug Classes

6.2. Global Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Seasonal Allergies

Perennial Allergies

Food Allergies

Skin Allergies

Insect Sting Allergies

6.3. Global Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Syrups

Nasal Sprays

Eye Drops

Injectables

6.4. Global Anti-Allergy Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Online Pharmacy

Hospital

Offline Pharmacy

Clinic

Other Applications

6.5. Global Anti-Allergy Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Children

Adults

Geriatric Population

Pregnant Women

6.6. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

First-Generation Antihistamines

Second-Generation Antihistamines

Third-Generation Antihistamines

6.7. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Corticosteroids

Nasal Corticosteroids

Inhaled Corticosteroids

Topical Corticosteroids

6.8. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Decongestants

Nasal Spray Decongestants

Topical Decongestants

6.9. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Leukotriene Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Leukotriene Receptor Antagonists

Leukotriene Synthesis Inhibitors

6.10. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cromolyn Sodium

Nedocromil Sodium

6.11. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunotherapy Agents

Biologics

Monoclonal Antibodies

7. Anti-Allergy Medicine Market Regional And Country Analysis

7.1. Global Anti-Allergy Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Anti-Allergy Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Allergy Medicine Market

8.1. Asia-Pacific Anti-Allergy Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Allergy Medicine Market

9.1. China Anti-Allergy Medicine Market Overview

9.2. China Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Allergy Medicine Market

10.1. India Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Allergy Medicine Market

11.1. Japan Anti-Allergy Medicine Market Overview

11.2. Japan Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Allergy Medicine Market

12.1. Australia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Allergy Medicine Market

13.1. Indonesia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Allergy Medicine Market

14.1. South Korea Anti-Allergy Medicine Market Overview

14.2. South Korea Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Allergy Medicine Market

15.1. Western Europe Anti-Allergy Medicine Market Overview

15.2. Western Europe Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Allergy Medicine Market

16.1. UK Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Allergy Medicine Market

17.1. Germany Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Allergy Medicine Market

18.1. France Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Allergy Medicine Market

19.1. Italy Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Allergy Medicine Market

20.1. Spain Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Allergy Medicine Market

21.1. Eastern Europe Anti-Allergy Medicine Market Overview

21.2. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Allergy Medicine Market

22.1. Russia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Allergy Medicine Market

23.1. North America Anti-Allergy Medicine Market Overview

23.2. North America Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Allergy Medicine Market

24.1. USA Anti-Allergy Medicine Market Overview

24.2. USA Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Allergy Medicine Market

25.1. Canada Anti-Allergy Medicine Market Overview

25.2. Canada Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Allergy Medicine Market

26.1. South America Anti-Allergy Medicine Market Overview

26.2. South America Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Allergy Medicine Market

27.1. Brazil Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Allergy Medicine Market

28.1. Middle East Anti-Allergy Medicine Market Overview

28.2. Middle East Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Allergy Medicine Market

29.1. Africa Anti-Allergy Medicine Market Overview

29.2. Africa Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Allergy Medicine Market Competitive Landscape And Company Profiles

30.1. Anti-Allergy Medicine Market Competitive Landscape

30.2. Anti-Allergy Medicine Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Allergy Medicine Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. AstraZeneca plc

31.3. Novartis AG

31.4. GSK plc

31.5. Amgen Inc.

31.6. Teva Pharmaceutical Industries Ltd.

31.7. Regeneron Pharmaceuticals Inc.

31.8. Perrigo Company plc

31.9. Cipla Limited

31.10. Dr. Reddy's Laboratories

31.11. Lupin Limited

31.12. Zydus Lifesciences Limited

31.13. Takeda Pharmaceutical Company Limited

31.14. Torrent Pharmaceuticals Ltd.

31.15. ALK-Abelló A/S

32. Global Anti-Allergy Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Allergy Medicine Market

34. Recent Developments In The Anti-Allergy Medicine Market

35. Anti-Allergy Medicine Market High Potential Countries, Segments and Strategies

35.1 Anti-Allergy Medicine Market In 2029 - Countries Offering Most New Opportunities

35.2 Anti-Allergy Medicine Market In 2029 - Segments Offering Most New Opportunities

35.3 Anti-Allergy Medicine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Anti-Allergy Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Anti-Allergy Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Leukotriene Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Anti-Allergy Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Anti-Allergy Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Pfizer Inc. Financial Performance
  • Table 83: Johnson & Johnson Financial Performance
  • Table 84: F. Hoffmann-La Roche AG Financial Performance
  • Table 85: Merck & Co. Inc. Financial Performance
  • Table 86: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Anti-Allergy Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Anti-Allergy Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Leukotriene Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Anti-Allergy Medicine Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Anti-Allergy Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Anti-Allergy Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Pfizer Inc. Financial Performance
  • Figure 83: Johnson & Johnson Financial Performance
  • Figure 84: F. Hoffmann-La Roche AG Financial Performance
  • Figure 85: Merck & Co. Inc. Financial Performance
  • Figure 86: Bayer AG Financial Performance

Frequently Asked Questions

Anti-allergy medicine refers to a broad category of pharmaceutical products designed to prevent or alleviate the symptoms caused by allergic reactions by targeting the immune system’s response to allergens such as pollen, dust, pet dander, insect stings, or certain foods and medications. These medicines help reduce symptoms such as sneezing, itching, runny nose, hives, and watery eyes and reduce discomfort caused by allergens. For further insights on the Anti Allergy Medicine market, request a sample here

The Anti Allergy Medicine market major growth driver - Growing Prevalence Of Allergies Fueling The Growth Of The Market Due To Rising Environmental Pollution And Increasing Asthma Cases. For further insights on the Anti Allergy Medicine market, request a sample here

The Anti Allergy Medicine market size has grown strongly in recent years. The anti-allergy medicine market size has grown strongly in recent years. It will grow from $38.84 billion in 2024 to $42.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of allergic diseases, growing awareness about allergy treatments, rising adoption of over-the-counter anti-allergy medicines, expansion of healthcare infrastructure, and growing improvements in diagnostic technologies. The anti-allergy medicine market size is expected to see strong growth in the next few years. It will grow to $58.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing incidence of allergies worldwide, rising demand for fast-acting anti-allergy drugs, growing geriatric population, expansion of online pharmacy channels, and increasing government initiatives for allergy awareness. Major trends in the forecast period include technology advancements in drug delivery systems, innovations in non-sedating antihistamines, developments in personalized allergy treatments, research and development in biologics for allergy, and integration of digital health tools for allergy management. For further insights on the Anti Allergy Medicine market, request a sample here

The anti-allergy medicine market covered in this report is segmented –
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, Mast Cell Stabilizers, Other Drug Classes
2) By Type Of Allergy: Seasonal Allergies, Perennial Allergies, Food Allergies, Skin Allergies, Insect Sting Allergies
3) By Formulation: Tablets, Capsules, Syrups, Nasal Sprays, Eye Drops, Injectables
4) By Application: Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Other Applications
5) By End User: Children, Adults, Geriatric Population, Pregnant Women

Subsegments:
1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines, Third-Generation Antihistamines
2) By Corticosteroids: Oral Corticosteroids, Nasal Corticosteroids, Inhaled Corticosteroids, Topical Corticosteroids
3) By Decongestants: Oral Decongestants, Nasal Spray Decongestants, Topical Decongestants
4) By Leukotriene Inhibitors: Leukotriene Receptor Antagonists, Leukotriene Synthesis Inhibitors
5) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil Sodium
6) By Other Drug Classes: Immunotherapy Agents, Biologics, Monoclonal Antibodies For further insights on the Anti Allergy Medicine market,
request a sample here

North America was the largest region in the anti-allergy medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-allergy medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Anti Allergy Medicine market, request a sample here.

Major companies operating in the anti-allergy medicine market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Perrigo Company plc, Cipla Limited, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd., ALK-Abelló A/S, Torii Pharmaceutical Co. Ltd., Biomay Aktiengesellschaft, Kaléo Inc., Immunomic Therapeutics Inc., Circassia Group plc, Sun Pharmaceutical Industries Ltd., Anergis S.A., Aravax Pty Ltd., DBV Technologies S.A., Desentum Oy. . For further insights on the Anti Allergy Medicine market, request a sample here.

Major trends in the Anti Allergy Medicine market include Targeted Allergy Therapy Gains Approval For Adolescent And Adult Use. For further insights on the Anti Allergy Medicine market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon